Medical Policies and Clinical Utilization Management Guidelines

Similar documents
Medical Policies and Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

BadgerCare Plus. Ambulance services: air and water Ambulance services: ground; nonemergent

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines First Quarter, 2017

Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Ambulance services: air and water Ambulance services: ground; nonemergent

Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Clinical UM Guidelines for Indiana, Kentucky, Missouri, Ohio and Wisconsin

Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines update

Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Outpatient Guidelines

Clinical Utilization Management Guidelines

Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

State: Virginia. Clinical Guidelines Applicable for Virginia

Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines update

Medical Policies and Clinical Utilization Management Guidelines

Special Notes Implementation Date by CO. State CG number CG title CG Category Original Current Version

Date - Current Version Implementation. Date - First Implementationby - CO 7/1/ /9/2012 7/1/2013 7/1/2013 4/16/2013 4/1/2016 1/1/2013 1/1/2013

Clinical Utilization Management Guidelines

Provider Newsletter. Table of Contents. Reimbursement Policy: Improve member medication regimen. Page 2

Medical Policies and Clinical Utilization Management Guidelines

Medical Policies and Clinical Utilization Management Guidelines

Medical policies update

Note: these medications are on the auto-exempt list thus they do not count toward the member script limit

Effective April 7, 2014 UTILIZATION MANAGEMENT STANDARD CLINICAL REVIEW PREAUTHORIZATION LIST IMPORTANT

Policy or Guideline Number. 1/1/2019 New DRUG Ibalizumab-uiyk (Trogarzo )

AIM Specialty Health

Prior Authorization List Effective February 2, 2015

Medical and claim payment policy activity

April 4, 2016 UTILIZATION MANAGEMENT STANDARD CLINICAL REVIEW PREAUTHORIZATION LIST

Medical and claim payment policy activity

Jan 30, Dear Provider:

Updates to Medical Policies and Clinical UM Guidelines

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

Anthem Blue Cross and Blue Shield GA Standard Preapproval CODE List 4/1/2019

sad EFFECTIVE DATE: POLICY LAST UPDATED:

2016 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015

OH, IN, KY, MO: Lumenos Health Savings Account, Lumenos Health Reimbursement Account, Lumenos Health Incentive Account

sad EFFECTIVE DATE: POLICY LAST UPDATED:

April 8, 2018 UTILIZATION MANAGEMENT STANDARD CLINICAL REVIEW PREAUTHORIZATION LIST

PA Category Name Code(s) Additional Notes ABA 0364T 0365T 0366T 0367T 0373T 0374T H G0396. Applied Behavioral Analysis stage 3*

Anthem Blue Cross and Blue Shield Central Region 2013 Blue Products Pre-Certification List for Indiana, Kentucky, Missouri, Ohio and Wisconsin

sad EFFECTIVE DATE: POLICY LAST UPDATED:

January 2016 News Bulletin

OH, IN, KY, MO: Lumenos Health Savings Account, Lumenos Health Reimbursement Account, Lumenos Health Incentive Account

Medical Policy and Clinical Guideline Updates 4Q17 Chart

MDwise Community Health Network Hoosier Healthwise Medical Services that Require Prior Authorization

Provider Alert. November 30, 2017

Oregon CPT Preapproval Grid

CUSTOMIZATIONS TO MCKESSON INTERQUAL CRITERIA Issue Date: December 19, 2013 Original Date: May 1, 2013

CUSTOMIZATION TO 21st EDITION Original Date: February 7, 2017 CARE GUIDELINES

Medical Pre-Authorization and Notification Requirements

Anthem Blue Cross and Blue Shield Central Region 2018 Blue Products Pre-Certification List for Indiana, Kentucky, Missouri, Ohio and Wisconsin

Outpatient Specialty Referral Request Types

Medical Services Protocol Updates

Medical Services Protocol Updates

Pre-authorization Form

UnitedHealthcare Notification/Prior Authorization Requirements Effective October 1, 2016

Pharmacy Services Request Types

Prior Authorization List for Physician Alliance of the Rockies, UnitedHealthcare Medicare Advantage Effective April 1, 2018

CUSTOMIZATIONS TO MILLIMAN CARE GUIDELINES 15 th EDITION Original Date: March 3, 2011

REVENUE CODE LIST REQUIRING CPT/HCPCS CODES FOR OUTPATIENT FACILITY CLAIMS

Medical Services Protocol Updates

Specialty Referrals. Start of Code Range (Procedure Low Code) Request Request Profile Description. End of Code Range (Procedure High Code)

Experimental and investigational procedure codes

Medical Services Protocol Updates

Medical and claim payment policy activity

MetroPlus Health Plan SCHEDULE OF BENEFITS MetroPlus Gold

Transcription:

Medical Policies and Clinical Utilization Management Guidelines Attached is a list of the Clinical UM Guidelines and/or Medical Policies adopted for. The full list of Medical Policies and Clinical Utilization Management (UM) Guidelines are publicly available on the Medical Policy (Coverage) and Clinical UM Guideline subsidiary website. Their purpose is to help you provide quality care by reducing inappropriate use of medical resources. InterQual Criteria or MCG care guidelines are used only for: Medical necessity review for medical inpatient concurrent review. Inpatient site of service appropriateness. Home health and outpatient rehabilitation. Medicaid state contracts, regulatory guidance and CMS requirements supersede InterQual Criteria, MCG care guidelines and our Medical Policy criteria. Note: We make determinations of medical necessity on a case-by-case basis in accordance with the definition of medical necessity. Please see Medical Necessity Criteria Policy ADMIN.0004 for the definition. If the request doesn t meet established criteria guidelines, it will be referred to the licensed physician reviewer with the appropriate clinical expertise. https://mediproviders.anthem.com/va HealthKeepers, Inc. is an independent licensee of the Blue Cross and Blue Shield Association. ANTHEM is a registered trademark of Anthem Insurance Companies, Inc. AVAPEC-1569-17 January 2018

Clinical Utilization Management Guidelines The Clinical Utilization Management (UM) Guidelines below were adopted by the medical operations committee for the Government Business Division effective August 31, 2018. Highlighted sections indicate a new guideline. For markets with carved-out pharmacy services, the applicable listings below are informational only. To view a full list of guidelines, visit https://mediproviders.anthem.com/va/pages/medical.aspx. CG-ADMIN-01 CG-ADMIN-02 CG-ANC-03 CG-ANC-04 CG-ANC-05 CG-ANC-06 CG-BEH-01 CG-BEH-02 CG-BEH-03 CG-BEH-04 CG-BEH-05 CG-BEH-07 CG-BEH-09 CG-BEH-10 CG-BEH-11 CG-BEH-12 CG-BEH-13 CG-BEH-14 CG-BEH-15 CG-DME-03 CG-DME-04 CG-DME-05 CG-DME-06 CG-DME-07 CG-DME-08 CG-DME-09 CG-DME-10 CG-DME-12 Clinical UM Guideline for Prepayment Review Medical Necessity Determinations When No Other Clinical UM Guideline Exists Clinically Equivalent Cost Effective Services Targeted Immune Modulators Acupuncture Ambulance Services: Air and Water Ambulance Services: Ground; Emergent Ambulance Services: Ground; Nonemergent Assessment for Autism Spectrum Disorders and Rett Syndrome Adaptive Behavioral Treatment for Autism Spectrum Disorder Psychiatric Disorder Treatment Substance-Related and Addictive Disorder Treatment Eating and Feeding Disorder Treatment Psychological Testing Assertive Community Treatment Basic Skills Training/Social Skills Training Mental Health Support Services Psychosocial Rehabilitation Services Targeted Case Management Intensive In-Home Behavioral Health Services Activity Therapy for Autism Spectrum Disorders and Rett Syndrome Neuromuscular Stimulation in the Treatment of Muscle Atrophy Electrical Nerve Stimulation, Transcutaneous, Percutaneous Cervical Traction Devices for Home Use Pneumatic Compression Devices for Lymphedema Augmentative and Alternative Communication Devices/ Speech-Generating Devices Infant Home Apnea Monitors Continuous Local Delivery of Analgesia to Operative Sites using an Elastomeric Infusion Pump During the Postoperative Period Durable Medical Equipment Home Phototherapy Devices for Neonatal Hyperbilirubinemia https://mediproviders.anthem.com/va HealthKeepers, Inc. is an independent licensee of the Blue Cross and Blue Shield Association. ANTHEM is a registered trademark of Anthem Insurance Companies, Inc., offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Commonwealth Coordinated Care Plus (CCC Plus) benefits to enrollees. AVAPEC-1868-18 October 2018

Page 2 of 9 CG-DME-13 Lower Limb Prosthesis CG-DME-15 Hospital Beds and Accessories CG-DME-16 Pressure Reducing Support Systems Groups 1, 2 and 3 CG-DME-18 Home Oxygen Therapy CG-DME-19 Therapeutic Shoes, Inserts or Modifications for Individuals with Diabetes CG-DME-20 Orthopedic Footwear CG-DME-21 External Infusion Pumps for the Administration of Drugs in the Home or Residential Care Settings CG-DME-22 Ankle-Foot and Knee-Ankle-Foot Orthotics (Braces) CG-DME-23 Lifting Devices for Use in the Home CG-DME-24 Wheeled Mobility Devices: Manual Wheelchairs Standard, Heavy Duty and Lightweight CG-DME-25 Seat Lift Mechanisms CG-DME-26 Back-Up Ventilators in the Home Setting CG-DME-30 Prothrombin Time Self-Monitoring Devices CG-DME-31 Wheeled Mobility Devices: Wheelchairs Powered, Motorized, With or Without Power Seating Systems and Power Operated Vehicles CG-DME-33 Wheeled Mobility Devices: Manual Wheelchairs Ultra Lightweight CG-DME-34 Wheeled Mobility Devices: Wheelchair Accessories CG-DME-35 Breastfeeding Pumps CG-DME-36 Pediatric Gait Trainers CG-DME-37 Air Conduction Hearing Aids CG-DME-39 Dynamic Low-Load Prolonged-Duration Stretch CG-DME-40 Electrical Bone Growth Stimulation CG-DME-41 Ultraviolet Light Therapy Delivery Devices for Home Use CG-DME-42 Nonimplantable Insulin Infusion and Blood Glucose Monitoring Devices CG-DME-43 High-Frequency Chest Compression Devices for Airway Clearance CG-DME-44 Electric Tumor Treatment Field (TTF) CG-DME-45 Ultrasound Bone Growth Stimulation CG-DRUG-01 Off-Label Drug and Approved Orphan Drug Use CG-DRUG-03 Beta Interferons and Glatiramer Acetate for Treatment of Multiple Sclerosis CG-DRUG-04 Use of Low Molecular Weight Heparin Therapy, Fondaparinux (Arixtra ) and Direct Thrombin Inhibitors in the Outpatient Setting CG-DRUG-05 Recombinant Erythropoietin Products CG-DRUG-08 Enzyme Replacement Therapy for Gaucher Disease CG-DRUG-09 Immune Globulin Therapy CG-DRUG-11 Infertility Drugs CG-DRUG-14 Dihydroergotamine Mesylate (DHE) Injection for the Treatment of Migraine or Cluster Headaches in Adults CG-DRUG-16 White Blood Cell Growth Factors CG-DRUG-18 Nesiritide (Natrecro )

Page 3 of 9 CG-DRUG-19 Progesterone Therapy as a Technique to Prevent Preterm Delivery in High- Risk Women CG-DRUG-20 Enfuviritide (Fuzeon) CG-DRUG-21 Naltrexone (Vivitrol ) Injections for the Treatment of Alcohol and Opioid Dependence CG-DRUG-24 Repository Corticotropin Injection (H.P. Acthar Gel) CG-DRUG-25 Intravenous versus Oral Drug Administration in the Outpatient and Home Setting CG-DRUG-27 Clostridial Collagenase Histolyticum Injection CG-DRUG-28 Alglucosidase alfa (Lumizyme, Myozyme ) Oncology Drug Treatment Regimens for Adults CG-DRUG-31 Note: At this time, this guideline is not implemented for medical benefit determinations CG-DRUG-33 Palonosetron (Aloxi ) CG-DRUG-34 Docetaxel (Docefrez, Taxotere ) CG-DRUG-38 Pemetrexed Disodium (Alimta ) CG-DRUG-40 Bortezomib (Velcade ) CG-DRUG-41 Zoledronic acid CG-DRUG-42 Asparagine Specific Enzymes (Asparaginase) CG-DRUG-43 Natalizumab (Tysabri ) CG-DRUG-44 Pegloticase (Krystexxa ) CG-DRUG-45 Octreotide acetate (Sandostatin ; Sandostatin LAR Depot) CG-DRUG-46 Fosaprepitant (Emend ) CG-DRUG-47 Level of Care: Specialty Pharmaceuticals CG-DRUG-48 Azacitidine (Vidaza ) CG-DRUG-49 Doxorubicin Hydrochloride Liposome Injection CG-DRUG-50 Paclitaxel, protein-bound (Abraxane ) CG-DRUG-51 Romidepsin (Istodax ) CG-DRUG-52 Temsirolimus (Torisel ) CG-DRUG-53 Drug Dosage, Frequency and Route of Administration CG-DRUG-54 Agalsidase beta (Fabrazyme ) CG-DRUG-55 Elosulfase alfa (Vimizim ) CG-DRUG-56 Galsulfase (Naglazyme ) CG-DRUG-57 Idurasufase (Elaprase ) CG-DRUG-58 Laronidase (Aldurazyme ) CG-DRUG-59 Testosterone, Injectable CG-DRUG-60 Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications CG-DRUG-61 Gonadotropin Releasing Hormone Analogs for the Treatment of Nononcologic Indications CG-DRUG-62 Fulvestrant (FASLODEX ) CG-DRUG-63 Levoleucovorin Calcium (Fusilev ) CG-DRUG-64 FDA-Approved Biosimilar Products

Page 4 of 9 CG-DRUG-65 Tumor Necrosis Factor Antagonists CG-DRUG-66 Panitumumab (Vectibix ) CG-DRUG-67 Cetuximab (Erbitux ) CG-DRUG-68 Bevacizumab (Avastin ) for Non-Ophthalmologic Indications CG-DRUG-69 Ustekinumab (Stelera ) CG-DRUG-70 Eribulin mesylate (Halaven ) CG-DRUG-71 Ziv-aflibercept (Zaltrap ) CG-DRUG-72 Pertuzumab (Perjeta ) CG-DRUG-73 Denosumab (Prolia, Xgeva ) CG-DRUG-74 Canakinumab (Ilaris ) CG-DRUG-75 Romiplostim (Nplate ) CG-DRUG-76 Plerixafor Injection (Mozobil ) CG-DRUG-77 Radium Ra 223 Dichloride (Xofigo ) CG-DRUG-78 Antihemophilic Factors and Clotting Factors CG-DRUG-79 Siltuximab (Sylvant ) CG-DRUG-80 Cabazitaxel (Jevtana ) CG-DRUG-81 Tocilizumab (Actemra ) CG-DRUG-82 Prostacyclin Infusion Therapy and Inhalation Therapy for Treatment of Pulmonary Arterial Hypertension CG-DRUG-83 Growth Hormone CG-DRUG-84 Belimumab (Benlysta ) CG-DRUG-85 Tesamorelin (Egrifta ) CG-DRUG-86 Ocriplasmin (Jetrea ) Intravitreal Injection Treatment CG-DRUG-87 Vedolizumab (Entyvio ) CG-DRUG-88 Dupilumab (Dupixent ) CG-DRUG-89 Implantable and Extended-Release Buprenorphine-Containing Products CG-DRUG-90 Intravitreal Treatment for Retinal Vascular Conditions CG-DRUG-91 Intravitreal Corticosteroid Implants CG-DRUG-92 Alpha-1 Proteinase Inhibitor Therapy CG-DRUG-93 Sarilumab (Kevzara ) CG-DRUG-94 Rituximab (Rituxan ) for Non-Oncologic Indications CG-DRUG-95 Belatacept (Nulojix ) CG-DRUG-96 Ado-trastuzumab emtansine (Kadcla ) CG-DRUG-97 Rilonacept (Arcalyst ) CG-DRUG-98 Bendamustine Hydrochloride CG-DRUG-99 Elotuzumab (Empliciti ) CG-DRUG-100 Interferon gamma-1b (Actimmune ) CG-DRUG-101 Ixabepilone (Ixempra ) CG-DRUG-102 Olaratumab (Lartruvo ) CG-DRUG-103 Botulinum Toxin CG-DRUG-104 Omalizumab (Xolair ) CG-DRUG-105 Abatacept (Orencia ) CG-DRUG-106 Brentuximab Vedotin (Adcetris )

Page 5 of 9 CG-DRUG-107 CG-DRUG-108 CG-DRUG-109 CG-DRUG-110 CG-DRUG-111 CG-DRUG-112 CG-GENE-01 CG-GENE-02 CG-GENE-03 CG-GENE-04 CG-LAB-03 CG-LAB-09 CG-LAB-10 CG-LAB-11 CG-LAB-12 CG-LAB-13 CG-MED-02 CG-MED-05 CG-MED-08 CG-MED-19 CG-MED-21 CG-MED-22 CG-MED-23 CG-MED-24 CG-MED-26 CG-MED-28 CG-MED-32 CG-MED-34 CG-MED-35 CG-MED-37 CG-MED-38 CG-MED-39 CG-MED-40 CG-MED-41 CG-MED-42 CG-MED-44 CG-MED-45 CG-MED-46 CG-MED-47 CG-MED-48 Pharmacotherapy for Hereditary Angioedema Enteral Carbidopa and Levodopa Intestinal Gel Suspension Asfotase Alfa (Strensiq ) Naltrexone Implantable Pellets Sebelipase alfa (KANUMA ) Abaloparatide (Tymlos ) Injection Janus Kinase 2 (JAK2) V617F Gene Mutation Assay Analysis of KRAS Status BRAF Mutation Analysis Molecular Marker Evaluation of Thyroid Nodules Tropism Testing for HIV Management Drug Testing or Screening in the Context of Substance Use Disorder and Chronic Pain Zika Virus Testing Screening for Vitamin D Deficiency in Average-Risk Individuals Testing for Oral and Esophageal Cancer Skin Nerve Fiber Density Testing Esophageal ph Monitoring Ketogenic Diet for Treatment of Intractable Seizures Home Enteral Nutrition Custodial Care Anesthesia Services and Moderate ("Conscious") Sedation Neuropsychological Testing Home Health Electromyography and Nerve Conduction Studies Neonatal Levels of Care Iontophoresis for Medical Indications Ancillary Services for Pregnancy Complications Monitored Anesthesia Care for Gastrointestinal Endoscopic Procedures Retinal Telescreening Systems Intensive Programs for Pediatric Feeding Disorders Inpatient admission for Radiation Therapy for Cervical or Thyroid Cancer Central (Hip or Spine) Bone Density Measurement and Screening for Vertebral Fractures Using Dual Energy X-Ray Absorptiometry External Ambulatory Event Monitors to Detect Cardiac Arrhythmias Moderate to Deep Anesthesia Services for Dental Surgery in the Facility Setting Maternity Ultrasound in the Outpatient Setting Holter Monitors Transrectal Ultrasonography Ambulatory and Inpatient Video Electroencephalography Fundus Photography Scrotal Ultrasound

Page 6 of 9 CG-MED-49 CG-MED-50 CG-MED-51 CG-MED-52 CG-MED-53 CG-MED-54 CG-MED-55 CG-MED-56 CG-MED-57 CG-MED-58 CG-MED-59 CG-MED-61 CG-MED-62 CG-MED-63 CG-MED-64 CG-MED-65 CG-MED-66 CG-MED-67 CG-MED-68 CG-MED-69 CG-MED-70 CG-MED-71 CG-MED-72 CG-MED-73 CG-MED-74 CG-MED-75 CG-MED-76 CG-MED-77 CG-OR-PR-02 CG-OR-PR-03 CG-OR-PR-04 CG-OR-PR-05 CG-OR-PR-06 CG-REHAB-02 Auditory Brainstem Responses and Evoked Otoacoustic Emissions for Hearing Disorders Visual, Somatosensory and Motor Evoked Potentials Three-Dimensional Rendering of Imaging Studies Allergy Immunotherapy (Subcutaneous) Cervical Cancer Screening Using Cytology and Human Papillomavirus Testing Strapping Level of Care: Advanced Radiologic Imaging Non-Obstetrical Transvaginal Ultrasonography Cardiac Stress Testing with Electrocardiogram Coronary Artery Imaging: Contrast-Enhanced CT Angiography, Fractional Flow Reserve derived from CT, Coronary MRA and Cardiac MRI Upper Gastrointestinal Endoscopy Preoperative Testing for Low Risk Invasive Procedures and Surgeries Resting Electrocardiogram Screening in Adults Treatment of Hyperhidrosis Transcatheter Ablation of Arrhythmogenic Foci in the Pulmonary Veins as a Treatment of Atrial Fibrillation or Atrial Flutter (Radiofrequency and Cryoablation) Manipulation Under Anesthesia of the Spine and Joints other than the Knee Cryopreservation of Oocytes or Ovarian Tissue Melanoma Vaccines Therapeutic Apheresis Inhaled Nitric Oxide Wireless Capsule Endoscopy for Gastrointestinal Imagine and the Patency Capsule Wound Care in the Home Setting Hyperthermia for Cancer Therapy Hyperbaric Oxygen Therapy (Systemic/Topical) Implantable Ambulatory Event Monitors and Mobile Cardiac Telemetry Medical and Other Non-Behavioral Health Related Treatments for Autism Spectrum Disorders and Rett Syndrome Magnetic Source Imaging and Magnetoencephalography SPECT/CT Fusion Imaging Prefabricated and Prophylactic Knee Braces Custom-made Knee Braces Cranial Remodeling Bands and Helmets (Cranial Orthotics) Myoelectric Upper Extremity Prosthesis Devices Spinal Orthoses: Thoracic-Lumber-Sacral (TLSO), Lumbar-Sacral (LSO) and Lumber Outpatient Cardiac Rehabilitation

Page 7 of 9 CG-REHAB-03 CG-REHAB-04 CG-REHAB-05 CG-REHAB-06 CG-REHAB-07 CG-REHAB-08 CG-REHAB-10 CG-REHAB-11 CG-SURG-01 CG-SURG-03 CG-SURG-05 CG-SURG-07 CG-SURG-08 CG-SURG-09 CG-SURG-10 CG-SURG-11 CG-SURG-12 CG-SURG-15 CG-SURG-17 CG-SURG-18 CG-SURG-24 CG-SURG-25 CG-SURG-27 CG-SURG-28 CG-SURG-29 CG-SURG-30 CG-SURG-31 CG-SURG-32 CG-SURG-33 CG-SURG-34 CG-SURG-35 CG-SURG-36 CG-SURG-37 CG-SURG-38 CG-SURG-39 CG-SURG-40 CG-SURG-41 CG-SURG-42 CG-SURG-43 CG-SURG-44 Pulmonary Rehabilitation Physical Therapy Occupational Therapy Speech-Language Pathology Services Skilled Nursing and Skilled Rehabilitation Services (Outpatient) Private Duty Nursing in the Home Setting Level of Care: Outpatient Physical Therapy, Occupational Therapy and Speech-Language Pathology Services Cognitive Rehabilitation Colonoscopy Blepharoplasty, Blepharoptosis Repair and Brow Lift Maze Procedure Vertical Expandable Prosthetic Titanium Rib Sacral Nerve Stimulation as a Treatment of Neurogenic Bladder Secondary to Spinal Cord Injury Temporomandibular Disorders Ambulatory or Outpatient Surgery Center Procedures Surgical Treatment for Dupuytren s Contracture Penile Prosthesis Implantation Endometrial Ablation Trigger Point Injections Septoplasty Functional Endoscopic Sinus Surgery Injection Treatment for Morton's Neuroma Sex Reassignment Surgery Transcatheter Uterine Artery Embolization Lumbar Discography Tonsillectomy With or Without Adenoidectomy for Children Treatment of Keloids and Scar Revision Pain Management: Cervical, Thoracic and Lumbar Facet Injections Lumbar Fusion and Lumbar Total Disc Arthroplasty Diagnostic Infertility Surgery Intracytoplasmic Sperm Injection (ICSI) Adenoidectomy Destruction of Pre-Malignant Skin Lesions Lumbar Laminectomy, Hemi-laminectomy, Laminectomy and/or Discectomy Pain Management: Epidural Steroid Injections Cataract Removal Surgery for Adults Surgical Strabismus Correction Cervical Fusion Knee Arthroscopy Coronary Angiography in the Outpatient Setting

Page 8 of 9 CG-SURG-45 CG-SURG-46 CG-SURG-47 CG-SURG-48 CG-SURG-49 CG-SURG-50 CG-SURG-51 CG-SURG-52 CG-SURG-53 CG-SURG-54 CG-SURG-55 CG-SURG-56 CG-SURG-57 CG-SURG-58 CG-SURG-59 CG-SURG-60 CG-SURG-61 CG-SURG-62 CG-SURG-63 CG-SURG-65 CG-SURG-66 CG-SURG-67 CG-SURG-68 CG-SURG-69 CG-SURG-70 CG-SURG-71 CG-SURG-72 CG-SURG-73 CG-SURG-74 CG-SURG-75 CG-SURG-76 CG-SURG-77 CG-SURG-78 CG-SURG-79 CG-SURG-80 Bone Graft Substitutes Myringotomy and Tympanostomy Tube Insertion Surgical Interventions for Scoliosis and Spinal Deformity Elective Percutaneous Coronary Interventions Endovascular Techniques (Percutaneous or Open Exposure) for Arterial Revascularization of the Lower Extremities Assistant Surgeons Outpatient Cystourethroscopy Level of Care: Hospital-Based Ambulatory Surgical Procedures, including Endoscopic Procedures Elective Total Hip Arthroplasty Elective Total Knee Arthroplasty Intracardiac Electrophysiological Studies and Catheter Ablation Diagnostic Fiberoptic Flexible Laryngoscopy Diagnostic Nasal Endoscopy Radioactive Seed Localization of Nonpalpable Breast Lesions Vena Cava Filters Cervical Total Disc Arthroplasty Cryosurgical Ablation of Solid Tumors Outside the Liver Radiofrequency Ablation to Treat Tumors Outside the Liver Cardiac Resynchronization Therapy (CRT) With or Without an Implantable Cardioverter Defibrillator (CRT/ICD) for the Treatment of Heart Failure Recombinant Human Bone Morphogenetic Protein Implanted (Epidural and Subcutaneous) Spinal Cord Stimulators (SCS) Treatment of Osteochondral Defects Surgical Treatment of Femoroacetabular Impingement Sydnrome Meniscal Allograft Transplantation of the Knee Gastric Electrical Stimulation Reduction Mammaplasty Endothelial Keratoplasty Balloon Sinus Ostial Dilation Total Ankle Replacement Transanal Endoscopic Microsurgical (TEM) Excision of Rectal Lesions Carotid, Vertebral and Intracranial Artery Stent Placement With or Without Angioplasty Refractive Surgery Locally Ablative Techniques for Treating Primary and Metastatic Liver Malignancies Implantable Infusion Pumps Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Embolization (TAE) for Treating Primary or Metastatic Liver Tumore

Page 9 of 9 CG-SURG-81 CG-SURG-82 CG-SURG-83 CG-SURG-84 CG-SURG-85 CG-SURG-86 CG-SURG-87 CG-SURG-88 CG-SURG-89 CG-THER- RAD-03 CG-THER- RAD-04 CG-THER- RAD-07 CG-TRANS-03 Cochlear Implants and Auditory Brainstem Implants Bone-Anchored and Bone-Conduction Hearing Aids Bariatric Surgery and Other Treatments for Clinically Severe Obesity Mandibular/Maxillary (Orthognathic) Surgery Hip Resurfacing Endovascular/Endoluminal Repair of Aortic Aneurysms, Aortoiliac Disease, Aortic Dissection and Aortic Transection Nasal Surgery for the Treatment of Obstructive Sleep Apnea and Snoring Previous title: Nasal Surgery for the Treatment of Obstructive Sleep Apnea (OSA) and Snoring Mastectomy for Gynecomastia Radiofrequency Neurolysis and Pulsed Radiofrequency Therapy for Trigeminal Neuralgia Radioimmunotherapy and Somatostatin Receptor Targeted Radiotherapy Selective Internal Radiation Therapy of Primary or Metastatic Liver Tumors Intravascular Brachytherapy (Coronary and Non-Coronary) Donor Lymphocyte Infusion for Hematologic Malignancies after Allogeneic Hematopoietic Progenitor Cell Transplantation